Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Boehringer Ingelheim sues Laurus over Jardiance patent
Boehringer Ingelheim Pharmaceuticals and related entities filed a lawsuit against Laurus Labs and Laurus Generics in Delaware, alleging patent infringement related to a generic version of Jardiance and seeking injunctive relief and monetary damages.
2021
Merck files Januvia patent suit against Laurus
Merck Sharp & Dohme Corp. filed a patent suit in the District of Delaware against Laurus Labs Limited and Laurus Generics Inc. after the defendants submitted an ANDA to the FDA seeking to produce a generic version of Januvia. Merck is seeking a declaration of patent infringement; the filing describes the alleged infringement, not a court determination.
2021
Laurus Labs completes acquisition of 72.55% of Richcore
Laurus Labs completed its acquisition of a 72.55% stake in Richcore Lifesciences Private Limited. Richcore became a subsidiary of Laurus Labs effective that day.